FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q35949553> ?p ?o ?g. }

• Q35949553 description "2016 nî lūn-bûn" @default.
• Q35949553 description "2016年の論文" @default.
• Q35949553 description "2016年論文" @default.
• Q35949553 description "2016年論文" @default.
• Q35949553 description "2016年論文" @default.
• Q35949553 description "2016年論文" @default.
• Q35949553 description "2016年論文" @default.
• Q35949553 description "2016年论文" @default.
• Q35949553 description "2016年论文" @default.
• Q35949553 description "2016年论文" @default.
• Q35949553 description "2016年论文" @default.
• Q35949553 description "2016年论文" @default.
• Q35949553 description "2016年论文" @default.
• Q35949553 description "2016년 논문" @default.
• Q35949553 description "article científic" @default.
• Q35949553 description "article scientific" @default.
• Q35949553 description "article scientifique (publié 2016)" @default.
• Q35949553 description "articol științific" @default.
• Q35949553 description "articolo scientifico" @default.
• Q35949553 description "artigo científico (publicado na 2016)" @default.
• Q35949553 description "artigo científico (publicado na 2016)" @default.
• Q35949553 description "artigo científico" @default.
• Q35949553 description "artikull shkencor" @default.
• Q35949553 description "artikulong pang-agham" @default.
• Q35949553 description "artykuł naukowy" @default.
• Q35949553 description "artículo científico publicado en 2016" @default.
• Q35949553 description "artículu científicu espublizáu en 2016" @default.
• Q35949553 description "bilimsel makale" @default.
• Q35949553 description "bài báo khoa học" @default.
• Q35949553 description "mokslinis straipsnis" @default.
• Q35949553 description "naučni članak" @default.
• Q35949553 description "scienca artikolo" @default.
• Q35949553 description "scientific article" @default.
• Q35949553 description "teaduslik artikkel" @default.
• Q35949553 description "tieteellinen artikkeli" @default.
• Q35949553 description "tudományos cikk" @default.
• Q35949553 description "vedecký článok" @default.
• Q35949553 description "vetenskaplig artikel" @default.
• Q35949553 description "videnskabelig artikel (udgivet 2016)" @default.
• Q35949553 description "vitenskapelig artikkel" @default.
• Q35949553 description "vitskapeleg artikkel" @default.
• Q35949553 description "vědecký článek" @default.
• Q35949553 description "wetenschappelijk artikel" @default.
• Q35949553 description "wissenschaftlicher Artikel" @default.
• Q35949553 description "επιστημονικό άρθρο" @default.
• Q35949553 description "мақолаи илмӣ" @default.
• Q35949553 description "мақолаи илмӣ" @default.
• Q35949553 description "наукова стаття, опублікована в березні 2016" @default.
• Q35949553 description "научна статия" @default.
• Q35949553 description "научная статья" @default.
• Q35949553 description "научни чланак" @default.
• Q35949553 description "научни чланак" @default.
• Q35949553 description "գիտական հոդված" @default.
• Q35949553 description "מאמר מדעי" @default.
• Q35949553 description "سائنسی مضمون" @default.
• Q35949553 description "مقالة علمية" @default.
• Q35949553 description "مقالهٔ علمی" @default.
• Q35949553 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q35949553 description "บทความทางวิทยาศาสตร์" @default.
• Q35949553 description "სამეცნიერო სტატია" @default.
• Q35949553 name "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 name "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 name "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 type Item @default.
• Q35949553 label "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 label "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 label "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 prefLabel "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 prefLabel "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 prefLabel "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 P1433 Q35949553-1786DE61-FC85-4724-B2EF-CB04D339F835 @default.
• Q35949553 P1476 Q35949553-F596183B-BC44-4E40-8A8B-8794F737D713 @default.
• Q35949553 P2093 Q35949553-0669ADE2-0750-4176-B402-6031E33B1F3F @default.
• Q35949553 P2093 Q35949553-0AF1A812-46D1-4EF8-85DB-46BB934F0191 @default.
• Q35949553 P2093 Q35949553-0F68FF0D-FED9-49B1-B700-30710E290C71 @default.
• Q35949553 P2093 Q35949553-126A121B-125A-4C0F-80D4-7B4CC59DAAFF @default.
• Q35949553 P2093 Q35949553-218C4E45-7E86-481F-A5E0-123F305B2659 @default.
• Q35949553 P2093 Q35949553-261AD00D-7274-4A20-BEDC-A7784C32FF9D @default.
• Q35949553 P2093 Q35949553-304CCC40-B4AF-4082-A381-63A9001A4F7C @default.
• Q35949553 P2093 Q35949553-35CA1C87-993D-4EA8-ACF4-9A79E31CA7B4 @default.
• Q35949553 P2093 Q35949553-6D184C9F-DCFC-413B-AB9A-C2AF816EF019 @default.
• Q35949553 P2093 Q35949553-8FD63FB7-B09D-4076-894C-ABE86AD3B947 @default.
• Q35949553 P2093 Q35949553-CAB9C2D9-5016-442A-BB4D-ABDECCA405D7 @default.
• Q35949553 P2093 Q35949553-D13558DA-7F79-4EBA-BB24-B8559C92BA96 @default.
• Q35949553 P2093 Q35949553-FAC05CEF-1883-473E-8EB8-7295B0C23BDB @default.
• Q35949553 P304 Q35949553-E7347327-B7A4-411D-A178-596813DEF6C2 @default.
• Q35949553 P31 Q35949553-79F3A064-4BF8-4A1D-96A5-5443B2BAE4E1 @default.
• Q35949553 P356 Q35949553-B0ED8BC1-53F1-4837-8246-7C054D7CB8E0 @default.
• Q35949553 P407 Q35949553-2C998449-0534-440F-A50B-4D05622E089E @default.
• Q35949553 P433 Q35949553-FA950708-8DE1-4907-8F71-E59BC48570EF @default.
• Q35949553 P478 Q35949553-E163FE74-E896-47D4-AA89-0557D6864665 @default.
• Q35949553 P577 Q35949553-89315D6E-A861-4810-BB48-8E4ABE66CD3E @default.
• Q35949553 P698 Q35949553-7A2DA8EA-0F2B-4AFC-900B-EFD111711CC3 @default.
• Q35949553 P356 ACS.JMEDCHEM.5B01528 @default.
• Q35949553 P698 26954848 @default.
• Q35949553 P1433 Q900316 @default.
• Q35949553 P1476 "Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Rel" @default.
• Q35949553 P2093 "Ayumu Sato" @default.
• Q35949553 P2093 "Haruhiko Kuno" @default.
• Q35949553 P2093 "Hiroshi Nagabukuro" @default.

• next